1. Home
  2. PMT vs PCRX Comparison

PMT vs PCRX Comparison

Compare PMT & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PennyMac Mortgage Investment Trust of Beneficial Interest

PMT

PennyMac Mortgage Investment Trust of Beneficial Interest

HOLD

Current Price

$13.13

Market Cap

1.1B

Sector

Real Estate

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$26.32

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMT
PCRX
Founded
2009
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
2009
2011

Fundamental Metrics

Financial Performance
Metric
PMT
PCRX
Price
$13.13
$26.32
Analyst Decision
Hold
Strong Buy
Analyst Count
5
7
Target Price
$14.13
$32.86
AVG Volume (30 Days)
1.1M
916.7K
Earning Date
01-29-2026
11-06-2025
Dividend Yield
12.14%
N/A
EPS Growth
N/A
N/A
EPS
0.92
0.47
Revenue
$564,655,000.00
$716,791,000.00
Revenue This Year
N/A
$6.24
Revenue Next Year
$29.66
$9.53
P/E Ratio
$14.37
$55.91
Revenue Growth
N/A
3.14
52 Week Low
$11.60
$18.17
52 Week High
$14.93
$27.64

Technical Indicators

Market Signals
Indicator
PMT
PCRX
Relative Strength Index (RSI) 63.94 64.48
Support Level $12.49 $25.48
Resistance Level $12.71 $27.16
Average True Range (ATR) 0.21 1.00
MACD 0.03 0.15
Stochastic Oscillator 79.19 77.18

Price Performance

Historical Comparison
PMT
PCRX

About PMT PennyMac Mortgage Investment Trust of Beneficial Interest

PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: